FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...